Sermorelin (Sermorelin Acetate)

The biologically active fragment of human growth hormone-releasing factor, consisting of GHRH(1-29)-amide. This N-terminal sequence is identical in several mammalian species, such as human, pig, and cattle. It is used to diagnose or treat patients with GROWTH HORMONE deficiency.
Also Known As:
Sermorelin Acetate; Allphar Serono Brand of Sermorelin Acetate; GHRH(1-29)NH2; GRF(1-29)NH2; Geref; Serono Brand of Sermorelin; Serono Serono Brand of Sermorelin Acetate; hGHRH(1-29)NH2; Sermorelin Serono Brand; Growth Hormone-Releasing Factor(1-29)Amide; Somatotropin-Releasing-Hormone(1-29)Amide; Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2
Networked: 8 relevant articles (0 outcomes, 1 trials/studies)

Drug Context: Research Results


1. Lawnicka, Hanna: 1 article (10/2009)
2. Stepień, Henryk: 1 article (10/2009)
3. Krupiński, Roman: 1 article (10/2009)
4. Stepień, Tomasz: 1 article (10/2009)
5. Siejka, Agnieszka: 1 article (10/2009)
6. Komorowski, Jan: 1 article (10/2009)
7. Sacewicz, Małgorzata: 1 article (10/2009)

Related Diseases

1. Acromegaly
2. Body Weight (Weight, Body)
3. Neuroendocrine Tumors (Neuroendocrine Tumor)
4. Neoplasms (Cancer)
5. Graves Disease (Basedow Disease)

Related Drugs and Biologics

1. Growth Hormone (Somatotropin)
2. Chromogranin A
3. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
4. Galanin
5. Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)
6. MZ 5-156

Related Therapies and Procedures

1. Intravenous Injections